Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry

International Review of Psychiatry

Volumn 23, Issue 5, 2011, Pages 445-453

  Croarkin, Paul E ^a   Wall, Christopher A ^a   Lee, Jon ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BENEFICENCE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN ELECTROPHYSIOLOGY; CHILD PSYCHIATRY; CHILDHOOD DEPRESSION RATING SCALE; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROMYOGRAPHY; GILLES DE LA TOURETTE SYNDROME; HUMAN; INFORMED CONSENT; INHIBITION KINETICS; MAJOR DEPRESSION; MEDICAL ETHICS; MOOD DISORDER; NEUROPHYSIOLOGY; OBSESSIVE COMPULSIVE DISORDER; POLYPHARMACY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SELF REPORT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; VENTROMEDIAL PREFRONTAL CORTEX;

ADOLESCENT; ADOLESCENT BEHAVIOR; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR; DEPRESSIVE DISORDER; HUMANS; MINORITY HEALTH; NEUROPHYSIOLOGY; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; THERAPIES, INVESTIGATIONAL; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84855237434     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2011.623688     Document Type: Article

References (77)

1. Aman M.G., Singh N.N., Stewart A.W. & Field C.J. (1985). Psychometric characteristics of the aberrant behavior checklist . American Journal of Mental Deficiency , 89, 492-502. (Pubitemid 15104763)
2. Bajbouj M., Lisanby S.H., Lang U.E., Danker-Hopfe H., Heuser I. & Neu P. (2006). Evidence for impaired cortical inhibition in patients with unipolar major depression. Biological Psychiatry , 59 , 395-400. (Pubitemid 43289217)
3. Badawy R.A., Macdonell R.A., Berkovic S.F., Newton M.R. & Jackson G.D. (2010). Predicting seizure control: Cortical excitability and antiepileptic medication. Annals of Neurology , 67, 64-73.
4. Baron-Cohen S., Wheelwright S., Skinner R., Martin J. & Clubley E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders , 31, 5-17.
5. Baruth J.M., Casanova M.F., El-Baz A., Horrell T., Mathai G., Sears L. & Sokhadze E. (2010). Low-frequency repetitive transcranial magnetic stimulation (rTMS) modulates evokedgamma frequency oscillations in autism spectrum disorder (ASD). Journal of Neurotherapy , 14 , 179-194.
6. Bloch Y., Grisaru N., Harel E.V., Beitler G., Faivel N., Ratzoni G., ⋯Levkovitz Y. (2008). Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: An open-label study. Journal of ECT , 24 , 156-159.
7. Bloch Y., Harel H.V., Aviram S., Govezensky J., Ratzoni G. & Levkovitz Y. (2010). Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD subjects: A randomized controlled pilot study. World Journal of Biological Psychiatry , 11 , 755-758.
8. Blumberger D.M., Mulsant B.H., Fitzgerald P.B., Rajji T.K., Ravindran A.V., Young L.T., ⋯Daskalakis Z.J. (2011). A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World Journal of Biological Psychiatry , in Press.
9. Chae J.H., Nahas Z., Wassermann E., Li X., Sethuraman G., Gilbert D., ⋯ George M.S. (2004). A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cognitive and Behavioral Neurology , 17 , 109-117. (Pubitemid 38747406)
10. Chen R., Samii A., Canos M., Wassermann E.M., & Hallett M. (1997). Effects of phenytoin on cortical excitability in humans. Neurology , 49 , 881-883. (Pubitemid 27428043)
11. Constantino J.N., Davis S.A., Todd R.D., Schindler M.K., Gross M.M., Brophy S.L., ⋯Reich W. (2003).Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders , 33 , 427-433. (Pubitemid 37127938)
12. Croarkin P.E., Levinson A.J. & Daskalakis Z.J. (2011a). Evidence for GABAergic inhibitory deficits in major depressive disorder. Neuroscience and Biobehavioral Reviews , 35 , 818-825.
13. Croarkin P.E., Wall C.A., Nakonezny P.N., Buyukdura J.S., Husain M.M., Sampson S., ⋯Kozel F.A. (2011b) Increased cortical excitability with prefrontal high frequency repetitive transcranial magnetic stimulation (rTMS) in adolescents with treatment resistant major depressive disorder (MDD). Journal of Child and Adolescent Psychopharmacology , in Press.
14. Croarkin P.E., Wall C.A., McClintock S.M., Kozel F.A., Husain M.M. & Sampson S.M. (2010). The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. Journal of ECT , 26 , 323-329.
15. D'Agati D., Bloch Y., Levkovitz Y. & Reti I. (2010). rTMS for adolescents: Safety and efficacy considerations. Psychiatry Research , 177 , 280-285.
16. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B. & Chen R. (2002a). Transcranial magnetic stimulation: A new investigational and treatment tool in psychiatry. Journal of Neuropsychiatry and Clinical Neuroscience , 14 , 406-415. (Pubitemid 35265987)
17. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R.B. & Kapur S. (2002b). Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Archives of General Psychiatry , 59 , 347-354. (Pubitemid 34275253)
18. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B., Fountain S.I. & Chen R. (2005). Reduced cerebellar inhibition in schizophrenia: A preliminary study. American Journal of Psychiatry , 162 , 1203-1205. (Pubitemid 40770706)
19. Daskalakis Z.J., Farzan F., Barr M.S., Maller J.J., Chen R. & Fitzgerald P.B. (2008b). Long-interval cortical inhibition from the dorsolateral prefrontal cortex: A TMS-EEG study. Neuropsychopharmacology , 33 , 2860-2869.
20. Daskalakis Z.J., Fitzgerald P.B. & Christensen B.K. (2007). The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Research Reviews , 56 , 427-442. (Pubitemid 350176600)
21. Daskalakis Z.J., Levinson A.J. & Fitzgerald P.B. (2008a). Repetitive transcranial magnetic stimulation for major depressive disorder: A review. Canadian Journal of Psychiatry , 53 , 555-566.
22. Davis M.H. (1980). A multidimensional approach to individual differences in empathy. Catalog of Selected Documents in Psychology , 10 , 85.
23. Doane J.A., Falloon I.R., Goldstein M.J. & Mintz J. (1985). Parenting affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry , 13 , 261-276.
24. DuPaul G.J., Reid R., Power T.J., Anastopoulos A.D. (1998). ADHD Rating Scale-IV. New York: Guilford
25. Enticott P.G., Kennedy H.A., Zangen A., & Fitzgerald P.B. (2011). Deep repetitive transcranial magnetic stimulation associated with improved social functioning in a young woman with an autism spectrum disorder. Journal of ECT , 27 41-43.
26. Enticott P.G., Rinehart N.J., Tonge B.J., Bradshaw J.L. & Fitzgerald P.B. (2010). A preliminary transcranial magnetic stimulation study of cortical inhibition and excitability in highfunctioning autism and Asperger disorder. Developmental Medicine and Child Neurology , 52 , e179 - 183.
27. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B. & Daskalakis Z.J. (2010a). Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain , 133 , 1505-1514.
28. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., Daskalakis Z.J. (2010b). Reliability of longinterval cortical inhibition in healthy human subjects: A TMSEEG study. Journal of Neurophysiology , 104 , 1339-1346.
29. Fitzgerald P.B., Benitez J., Daskalakis J.Z., De Castella A. & Kulkarni J. (2006). The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World Journal of Biological Psychiatry , 7 , 119-122. (Pubitemid 43738910)
30. Frye R.E., Rotenberg A., Ousley M. & Pascual-Leone A. (2008). Transcranial magnetic stimulation in child neurology: Current and future directions. Journal of Child Neurology , 23 , 79-96.
31. Garvey M.A. & Gilbert D.L. (2004). Transcranial magnetic stimulation in children. European Journal of Paediatric Neurology , 8 , 7-19. (Pubitemid 38248078)
32. Garvey M.A., Ziemann U., Bartko J.J., Denckla M.B., Barker C.A. & Wassermann E.M. (2003). Cortical correlates of neuromotor development in healthy children. Clinical Neurophysiology , 114 , 1662-1670. (Pubitemid 37025799)
33. Gazzaniga M. (2005) The Ethical Brain. Washington, DC: Dana Press.
34. Geinisman Y., deToledo M.L. & Morrell F. (1994). Comparison of structural synaptic modifications induced by long-term potentiation in the hippocampal gyrus of young adult and aged rats. Annals of the New York Academy of Sciences , 747 , 452-466.
35. George M.S., Bohing D.E., Lorberbaum J.P., Nahas Z., Andersen B., Borckardt J.J., ⋯Rastogi (2007). Overview of transcranial magnetic stimulation: History, mechanisms, physics, and safety. In M.S. George & R. H. Belmaker (Eds), Transcranial Magnetic Stimulation in Clinical Psychiatry (pp.) Arlington, VA: American Psychiatric Publishing. 1-25
36. Gilbert D.L., Ridel K.R., Sallee F.R., Zhang J., Lipps T.D. & Wassermann E.M. (2005a). Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology , 31 , 442-449. (Pubitemid 43113408)
37. Gilbert D.L., Sallee F.R., Zhang J., Lipps T.D. & Wassermann E.M. (2005b). Transcranial magnetic stimulation-evoked cortical inhibition: A consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome. Biological Psychiatry , 57 , 1597-1600. (Pubitemid 40805392)
38. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C. & Wasserman E.M. (2000). Altered cortical excitability in obsessive - compulsive disorder. Neurology , 54 , 142-147. (Pubitemid 30038752)
39. Guy W. (1976). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration.
40. Hoffman R.E., Hawkins K.A., Gueorguieva R., Boutros N.N., Rachid F., Carroll K. & Krystal J.H. (2003). Transcranial magnetic stimulation of left temporoparietal cortex and medication- resistant auditory hallucinations. Archives of General Psychiatry , 60 , 49-56. (Pubitemid 36070864)
41. Illes J., Gallo M. & Kirschen M.P. (2006) An ethics perspective on transcranial magnetic stimulation (TMS) and human modulation. Behavioral Neurology , 17 , 149-157. (Pubitemid 44815296)
42. Jardri R., Lucas B., Delevoye-Turrell Y., Delmaire C., Delion P., Thomas P. & Goeb J.L. (2007). An 11-year-old boy with drugresistant schizophrenia treated with temporo-parietal rTMS. Molecular Psychiatry , 12 , 320. (Pubitemid 46496839)
43. Jotterand F., McClintock S.M., Alexander A.A. & Husain M.M. (2010). Ethics and informed consent of vagus nerve stimulation (VNS) for patients with treatment-resistant depression (TRD). Neuroethics , 3 13-22.
44. Kay S.R., Fiszbein A. & Opler L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin , 13 , 261-276. (Pubitemid 18039085)
45. Kozel F.A. (2010). Identifying phronotypes in psychiatry. Frontiers in Psychiatry , 141 , 1-5.
46. Kozel F.A., Tian F., Dhamne S., Croarkin P.E., McClintock S.M., Elliott A., ⋯Liu H. (2009). Using simultaneous repetitive Transcranial Magnetic Stimulation/functional Near Infrared Spectroscopy (rTMS/fNIRS) to measure brain activation and connectivity. Neuroimage , 47 , 1177-1184.
47. Kwon H.J., Lim W.S., Lim M.H., Lee S.J., Hyun J.K., Chae J.H. & Paik K.C. (2011). 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome. Neuroscience Letters , 492 , 1-4.
48. Lam K.S. & Aman M.G. (2007). The repetitive behavior scalerevised: Independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders , 37 , 855-866. (Pubitemid 46790783)
49. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J. & Cohen D.J. (1989). The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry , 28 , 566-573. (Pubitemid 19196295)
50. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M. & Daskalakis Z.J. (2010). Evidence of cortical inhibitory deficits in major depressive disorder. Biological Psychiatry , 67 , 458-464.
51. Lisanby S.H., Husain M.M., Rosenquist P.B., Maixner D., Gutierrez R., Krystal A., ⋯George M.S. (2009). Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: Clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology , 34 , 522-534.
52. Lisanby S.H., Kinnunen L.H. & Crupain M.J. (2002). Applications of TMS to therapy in psychiatry. Journal of Clinical Neurophysiology , 19 , 344-360. (Pubitemid 35304368)
53. Loo C., McFarquhar T. & Walter G. (2006). Transcranial magnetic stimulation in adolescent depression. Australasian Psychiatry , 14 , 81-85.
54. McClintock S.M., Freitas C., Oberman L., Lisanby S.H. & Pascual-Leone A. (2011). Transcranial magnetic stimulation: A neuroscientific probe of cortical function in schizophrenia. Biological Psychiatry , 70 , 19-27.
55. Moll G.H., Heinrich H., Trott G., Wirth S. & Rothenberger A. (2000). Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neuroscience Letters , 284 , 121-125. (Pubitemid 30193214)
56. Moll G.H., Heinrich H., Wischer S., Tergau F., Paulus W. & Rothenberger A. (1999a). Motor system excitability in healthy children: Developmental aspects from transcranial magnetic stimulation. Electroencephalography and Clinical Neurophysiology Supplements , 51 , 243-249.
57. Moll G.H., Wischer S., Heinrich H., Tergau F., Paulus W. & Rothenberger A. (1999b). Deficient motor control in children with tic disorder: Evidence from transcranial magnetic stimulation. Neuroscience Letters , 272 , 37-40.
58. Moreno J.D. (2003). Neuroethics: An agenda for neuroscience and society. Nature Reviews Neuroscience , 4 , 149-153. (Pubitemid 37271384)
59. Nezu A., Kimura S., Uehara S., Kobayashi T., Tanaka M. & Saito K. (1997). Magnetic stimulation of motor cortex in children: Maturity of corticospinal pathway and problem of clinical application. Brain Development , 19 , 176-180. (Pubitemid 27174016)
60. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., ⋯Sackeim H.A. (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biological Psychiatry , 62 , 1208-1216. (Pubitemid 350060890)
61. Orth M. & Rothwell J.C. (2009). Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome. Journal of Neurology Neurosurgery and Psychiatry , 80 , 29-34.
62. Poznanski E.O., Grossman J.A., Buchsbaum Y., Banegas M., Freeman L. & Gibbons R. (1984). Preliminary studies of the reliability and validity of the children's depression rating scale. Journal of the American Academy of Child and Adolescent Psychiatry , 23, 191-1917.
63. Quintana H. (2005). Transcranial magnetic stimulation in persons younger than the age of 18. Journal of ECT , 21 , 88-95. (Pubitemid 40800033)
64. Ridding M.C. & Rothwell J.C. (2007). Is there a future for therapeutic use of transcranial magnetic stimulation? Nature Reviews Neuroscience , 8 , 559-567. (Pubitemid 46985363)
65. Ritvo R.A., Ritvo E.R., Guthrie D., Yuwiller A., Ritvo M.J. & Weisbender L. (2008) A scale to assist the diagnosis of autism and Asperger's disorder in adults (RAADS): A pilot study. Journal of Autsim and Developmental Disorders , 38, 213-223. (Pubitemid 351161412)
66. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. & Safety of TMS Consensus Group (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology , 120, 2008 - 2039.
67. Sanislow C.A., Pine D.S., Quinn K.J., Kozak M.J., Garvey M.A., Heinssen R.K., ⋯Cuthbert B.N. (2010). Developing constructs for psychopathology research: Research domain criteria. Journal of Abnormal Psychology , 119 , 631-639.
68. Shaffer D., Gould M.S., Brasic J., Ambrosini P., Fisher P., Bird H. & Aluwahlia S. (1983). A children's global assessment scale (CGAS). Archives of General Psychiatry , 40, 1228-1231. (Pubitemid 13015019)
69. Sokhadze E., Baruth J., Tasman A., Mansoor M., Ramaswamy R., Sears. L., ⋯Casanova M.F. (2010). Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism. Applied Psychophysiology Biofeedback , 35 , 147-161.
70. Tergau F., Wischer S., Somal H.S., Nitsche M.A., Mercer A.J., Paulus W., Steinhoff B.J. (2003). Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: Insights from transcranial magnetic stimulation. Epilepsy Research , 56 , 67-77. (Pubitemid 37177056)
71. Wall C.A., Croarkin P.E., Sim L.A., Husain M.M., Janicak P.G., Kozel F.A., ⋯Sampson S. (2011) Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents. Journal of Clinical Psychiatry , 72: 63-69.
72. Walter G., Tormos J.M., Israel J.A. & Pascual-Leone A. (2001). Transcranial magnetic stimulation in young persons: A review of known cases. Journal of Child and Adolescent Psychopharmacology , 11 , 69-75. (Pubitemid 32295185)
73. Weaver L., Mace W., Akhtar U. Moss E., Rostain A. & O'Reardon J. (2008). Safety and efficacy of rTMS in treatment of ADHD in adolescents and young persons. Journal of ECT , 24 , 105-106.
74. Ziemann U. (1999). Intracortical inhibition and facilitation in the conventional paired TMS paradigm. Electroencephalography and Clinical Neurophysiology Supplements , 51 , 127-136.
75. Ziemann U. (2003). Pharmacology of TMS. Supplements in Clinical Neurophysiology , 56 , 226-231.
76. Ziemann U. (2004). TMS and drugs. Clinical Neurophysiology , 115 , 1717-1729. (Pubitemid 38952939)
77. Ziemann U., Chen R., Cohen L.G. & Hallett M. (1998). Dextromethorphan decreases the excitability of the human motor cortex. Neurology , 51 , 1320-1324.